The Carcinogens, Mutagens and Reprotoxic Substances Directive (CMRD) is entering into law in April 2024. It contains guidance for employers on how to keep healthcare staff safe at work when handling hazardous medicinal products. Watch this conversation between Susanne Cruikshank and José Manuel Martínez Sesmero to understand more about the importance of the CMRD.
Hazardous drug handling is a complex, interdisciplinary process that requires adherance to guidelines and recommendations. This editorial dicsusses the scope of some of the various available guidelines and the importance of keeping up to date with their changes.
In the first of 2 videos, Dr Sara Arenas discusses the role of the pharmacist in a multidisciplinary team. Pulling from her experience in medicine management, she describes the various aspects to consider in the financing and stocking of medicines.
One of the biggest concerns in the administration of hazardous drugs is the risk to those who come into contact with these drugs: patients, nurses and other health care professionals who administer the drug. Read this month’s editorial to explore ways of reducing these risks
The use of hazardous drugs (HD) for example cytotoxic drugs to treat cancer, has increased exponentially over the last 40 years. Sadly, however the awareness of the risks in administering HD has not increased at the same rate. Hear what two nurses have to say about the role of nurses in the handling of these drugs and what controls can be put in place to help mitigate the risks.
This one-pager summarises key information from three important documents for engineering controls: a joint position statement from the Oncology Nursing Society and the Hematology/Oncology Pharmacy Assocation, the USP <800>, and the NIOSH Hierarchy of Controls
Repetitive strain injury (RSI) is widespread in the medical workforce caused by repetitive movement or overuse. It can affect the muscles, nerves, or tendons mostly in the upper body. This factsheet provides an overview of recent facts and figures on the prevalence, risk factors, impact, and mitigation of RSI.
Dr Ana Herranz explores who is at risk of exposure to hazardous drugs, what precautions are put in place to protect them, who has responsibility for ensuring their safety and what guidelines and legislation exist to protect them. Watch her intro video or go direct to the module!
Hospital staff, patients and visitors are all affected if hazardous drugs are not handled safely. This module examines best practice in the preparation, administration and waste management of these drugs. Play the video to watch Johan Vandenbroucke introduce his updated module.
All healthcare professionals, and especially hospital pharmacists, need to concern themselves with ensuring the quality of injectable medications. This module explores the technologies used to maintain product integrity from preparation to administration. Watch Johan Vandenbrouke briefly introduce his updated module.